Report cover image

Global Cancer Diagnostics Market, 2025-2033

Publisher PreciseView Reports
Published Nov 03, 2025
Length 440 Pages
SKU # PCSR20610451

Description

Global Cancer Diagnostics Market, valued at USD 135.2 billion in 2024, is projected to reach USD 250.6 billion by 2033, registering a CAGR of 7.1% during the 2025-2033 forecast period. This robust expansion is propelled by surging cancer incidence exceeding 20 million cases annually worldwide, growing emphasis on early and precise detection through non-invasive methods, and rapid advancements in AI-assisted molecular tools like NGS growing at an 8% annual rate. The sector has intensified since 2023, driven by precision medicine surges and innovations in liquid biopsy for minimally invasive screening. Key trends include the dominance of imaging systems for broad accessibility, molecular diagnostics leading for targeted insights, and breast cancer applications at the forefront due to high prevalence. Lucrative prospects encompass healthcare modernizations in Asia Pacific's emerging economies like India for affordable ultrasound systems in hospitals, North American AI integrations for research institute efficiencies, and European regulatory-aligned liquid biopsy expansions for lung and prostate screenings. However, hurdles such as premium testing costs restricting uptake in regions like Latin America, complex approvals for novel assays in stringent markets, and data security risks in genetic profiling continue to challenge broader adoption. North America maintains over 35% of the share, anchored by the United States' advanced R&D and infrastructure, while Asia Pacific grows fastest at 8.0% CAGR, fueled by rising cases and digitalization in China.

Strategic segmentations empower targeted investments across categories, technologies, applications, cancer types, end-uses, and regions. Categories prioritize imaging systems for diagnostic foundation, technologies favor molecular diagnostics for precision, applications emphasize breast cancer for demand volume, and end-uses highlight hospitals for comprehensive care, with regional nuances-Asia Pacific for momentum, North America for innovation, and Europe for compliance mastery.

Market Segmentation:

By Product Type:

Imaging Systems (MRI Systems, CT Scanners, Ultrasound Systems, Mammography Systems, PET Systems)
Diagnostic Reagents & Kits
Biopsy Devices
Endoscopy Devices
Others

By Technology:

Imaging
Molecular Diagnostics (PCR-Based Tests, Next-Generation Sequencing, In Situ Hybridization)
Liquid Biopsy
Immunohistochemistry
Others

By Application:

Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Cervical Cancer
Blood Cancer
Others

By Cancer Type:

Carcinoma
Sarcoma
Leukemia
Lymphoma
Melanoma
Others

By End-Use:

Hospitals
Diagnostic Laboratories
Oncology Clinics
Research Institutes
Others

By Region:

North America (United States, Canada, Others)
Europe (United Kingdom, Germany, France, Italy, Spain, Others)
Asia Pacific (China, Japan, India, South Korea, Australia, Others)
Latin America (Brazil, Others)
Middle East & Africa (United Arab Emirates, Others)

Please note - Delivery Timeline: 2-3 Business Days

Table of Contents

440 Pages
Research Objective
MARKET SEGMENTATION
Scope of the Study
Key Questions Answered in the Report
Chapter 1 Research Methodology
1.1 Research Objective
1.2 Market Research Process
1.2.1 Data Procurement and Data Mining
1.2.2 Data Analysis and Standardization
1.2.3 Data Processing and Market Formulation
1.2.4 Data Validation
1.3 Market Research Approach
1.3.1 Residential Research
1.3.2 Commercial Research
1.3.3 Assumptions & Limitations
1.4 Year Considered for the Study
Chapter 2 Executive Summary
2.1 Global Cancer Diagnostics Market Snapshot
2.2 Global Cancer Diagnostics Market
Chapter 3 Market Variables and Scope
3.1 Introduction to Cancer Diagnostics
3.2 Classification and Scope
Chapter 4 Market Dynamics and Trends
4.1 Global Cancer Diagnostics Market Dynamics
4.2 Global Cancer Diagnostics Market Dynamics, Impact Analysis
4.3 Market Drivers
4.3.1 Driver 1
4.3.2 Driver 2
4.4 Market Restraints
4.4.1 Restraint 1
4.4.2 Restraint 2
4.5 Market Opportunity
4.5.1 Opportunity 1
4.5.2 Opportunity 2
Chapter 5 Premium Insights
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of Substitute Types
5.1.4 Rivalry among Existing Firms
5.1.5 Threat of New Entrants
5.2 Supply Chain Analysis
5.3 Market Share Analysis of Key Players, 2024
5.4 Market Entry Strategy Assessment
5.5 Strategic Recommendation for Stakeholders
Chapter 6 Global Cancer Diagnostics Market, By Product Type
6.1 Global Cancer Diagnostics Market, By Product Type, 2025 - 2033
6.2 Imaging Systems
6.2.1 MRI Systems
6.2.2 CT Scanners
6.2.3 Ultrasound Systems
6.2.4 Mammography Systems
6.2.5 PET Systems
6.3 Diagnostic Reagents & Kits
6.4 Biopsy Devices
6.5 Endoscopy Devices
6.6 Others
Chapter 7 Global Cancer Diagnostics Market, By Technology
7.1 Global Cancer Diagnostics Market, By Technology, 2025 - 2033
7.2 Imaging
7.3 Molecular Diagnostics
7.3.1 PCR-Based Tests
7.3.2 Next-Generation Sequencing
7.3.3 In Situ Hybridization
7.4 Liquid Biopsy
7.5 Immunohistochemistry
7.6 Others
Chapter 8 Global Cancer Diagnostics Market, By Application
8.1 Global Cancer Diagnostics Market, By Application, 2025 - 2033
8.2 Breast Cancer
8.3 Lung Cancer
8.4 Prostate Cancer
8.5 Colorectal Cancer
8.6 Cervical Cancer
8.7 Blood Cancer
8.8 Others
Chapter 9 Global Cancer Diagnostics Market, By Cancer Type
9.1 Global Cancer Diagnostics Market, By Cancer Type, 2025 - 2033
9.2 Carcinoma
9.3 Sarcoma
9.4 Leukemia
9.5 Lymphoma
9.6 Melanoma
9.7 Others
Chapter 10 Global Cancer Diagnostics Market, By End-Use
10.1 Global Cancer Diagnostics Market, By End-Use, 2025 - 2033
10.2 Hospitals
10.3 Diagnostic Laboratories
10.4 Oncology Clinics
10.5 Research Institutes
10.6 Others
Chapter 11 Global Cancer Diagnostics Market, By Region
11.1 Overview
11.2 North America
11.2.1 North America Cancer Diagnostics Market, By Country
11.2.2 North America Cancer Diagnostics Market, By Product Type
11.2.3 North America Cancer Diagnostics Market, By Technology
11.2.4 North America Cancer Diagnostics Market, By Application
11.2.5 North America Cancer Diagnostics Market, By Cancer Type
11.2.6 North America Cancer Diagnostics Market, By End-Use
11.2.7 United States
11.2.7.1 United States Cancer Diagnostics Market, By Product Type
11.2.7.2 United States Cancer Diagnostics Market, By Technology
11.2.7.3 United States Cancer Diagnostics Market, By Application
11.2.7.4 United States Cancer Diagnostics Market, By Cancer Type
11.2.7.5 United States Cancer Diagnostics Market, By End-Use
11.2.8 Canada
11.2.8.1 Canada Cancer Diagnostics Market, By Product Type
11.2.8.2 Canada Cancer Diagnostics Market, By Technology
11.2.8.3 Canada Cancer Diagnostics Market, By Application
11.2.8.4 Canada Cancer Diagnostics Market, By Cancer Type
11.2.8.5 Canada Cancer Diagnostics Market, By End-Use
11.2.9 Others
11.2.9.1 Others Cancer Diagnostics Market, By Product Type
11.2.9.2 Others Cancer Diagnostics Market, By Technology
11.2.9.3 Others Cancer Diagnostics Market, By Application
11.2.9.4 Others Cancer Diagnostics Market, By Cancer Type
11.2.9.5 Others Cancer Diagnostics Market, By End-Use
11.3 Europe
11.3.1 Europe Cancer Diagnostics Market, By Country
11.3.2 Europe Cancer Diagnostics Market, By Product Type
11.3.3 Europe Cancer Diagnostics Market, By Technology
11.3.4 Europe Cancer Diagnostics Market, By Application
11.3.5 Europe Cancer Diagnostics Market, By Cancer Type
11.3.6 Europe Cancer Diagnostics Market, By End-Use
11.3.7 United Kingdom
11.3.7.1 United Kingdom Cancer Diagnostics Market, By Product Type
11.3.7.2 United Kingdom Cancer Diagnostics Market, By Technology
11.3.7.3 United Kingdom Cancer Diagnostics Market, By Application
11.3.7.4 United Kingdom Cancer Diagnostics Market, By Cancer Type
11.3.7.5 United Kingdom Cancer Diagnostics Market, By End-Use
11.3.8 Germany
11.3.8.1 Germany Cancer Diagnostics Market, By Product Type
11.3.8.2 Germany Cancer Diagnostics Market, By Technology
11.3.8.3 Germany Cancer Diagnostics Market, By Application
11.3.8.4 Germany Cancer Diagnostics Market, By Cancer Type
11.3.8.5 Germany Cancer Diagnostics Market, By End-Use
11.3.9 France
11.3.9.1 France Cancer Diagnostics Market, By Product Type
11.3.9.2 France Cancer Diagnostics Market, By Technology
11.3.9.3 France Cancer Diagnostics Market, By Application
11.3.9.4 France Cancer Diagnostics Market, By Cancer Type
11.3.9.5 France Cancer Diagnostics Market, By End-Use
11.3.10 Italy
11.3.10.1 Italy Cancer Diagnostics Market, By Product Type
11.3.10.2 Italy Cancer Diagnostics Market, By Technology
11.3.10.3 Italy Cancer Diagnostics Market, By Application
11.3.10.4 Italy Cancer Diagnostics Market, By Cancer Type
11.3.10.5 Italy Cancer Diagnostics Market, By End-Use
11.3.11 Spain
11.3.11.1 Spain Cancer Diagnostics Market, By Product Type
11.3.11.2 Spain Cancer Diagnostics Market, By Technology
11.3.11.3 Spain Cancer Diagnostics Market, By Application
11.3.11.4 Spain Cancer Diagnostics Market, By Cancer Type
11.3.11.5 Spain Cancer Diagnostics Market, By End-Use
11.3.12 Others
11.3.12.1 Others Cancer Diagnostics Market, By Product Type
11.3.12.2 Others Cancer Diagnostics Market, By Technology
11.3.12.3 Others Cancer Diagnostics Market, By Application
11.3.12.4 Others Cancer Diagnostics Market, By Cancer Type
11.3.12.5 Others Cancer Diagnostics Market, By End-Use
11.4 Asia Pacific
11.4.1 Asia Pacific Cancer Diagnostics Market, By Country
11.4.2 Asia Pacific Cancer Diagnostics Market, By Product Type
11.4.3 Asia Pacific Cancer Diagnostics Market, By Technology
11.4.4 Asia Pacific Cancer Diagnostics Market, By Application
11.4.5 Asia Pacific Cancer Diagnostics Market, By Cancer Type
11.4.6 Asia Pacific Cancer Diagnostics Market, By End-Use
11.4.7 China
11.4.7.1 China Cancer Diagnostics Market, By Product Type
11.4.7.2 China Cancer Diagnostics Market, By Technology
11.4.7.3 China Cancer Diagnostics Market, By Application
11.4.7.4 China Cancer Diagnostics Market, By Cancer Type
11.4.7.5 China Cancer Diagnostics Market, By End-Use
11.4.8 Japan
11.4.8.1 Japan Cancer Diagnostics Market, By Product Type
11.4.8.2 Japan Cancer Diagnostics Market, By Technology
11.4.8.3 Japan Cancer Diagnostics Market, By Application
11.4.8.4 Japan Cancer Diagnostics Market, By Cancer Type
11.4.8.5 Japan Cancer Diagnostics Market, By End-Use
11.4.9 India
11.4.9.1 India Cancer Diagnostics Market, By Product Type
11.4.9.2 India Cancer Diagnostics Market, By Technology
11.4.9.3 India Cancer Diagnostics Market, By Application
11.4.9.4 India Cancer Diagnostics Market, By Cancer Type
11.4.9.5 India Cancer Diagnostics Market, By End-Use
11.4.10 South Korea
11.4.10.1 South Korea Cancer Diagnostics Market, By Product Type
11.4.10.2 South Korea Cancer Diagnostics Market, By Technology
11.4.10.3 South Korea Cancer Diagnostics Market, By Application
11.4.10.4 South Korea Cancer Diagnostics Market, By Cancer Type
11.4.10.5 South Korea Cancer Diagnostics Market, By End-Use
11.4.11 Australia
11.4.11.1 Australia Cancer Diagnostics Market, By Product Type
11.4.11.2 Australia Cancer Diagnostics Market, By Technology
11.4.11.3 Australia Cancer Diagnostics Market, By Application
11.4.11.4 Australia Cancer Diagnostics Market, By Cancer Type
11.4.11.5 Australia Cancer Diagnostics Market, By End-Use
11.4.12 Others
11.4.12.1 Others Cancer Diagnostics Market, By Product Type
11.4.12.2 Others Cancer Diagnostics Market, By Technology
11.4.12.3 Others Cancer Diagnostics Market, By Application
11.4.12.4 Others Cancer Diagnostics Market, By Cancer Type
11.4.12.5 Others Cancer Diagnostics Market, By End-Use
11.5 Latin America
11.5.1 Latin America Cancer Diagnostics Market, By Country
11.5.2 Latin America Cancer Diagnostics Market, By Product Type
11.5.3 Latin America Cancer Diagnostics Market, By Technology
11.5.4 Latin America Cancer Diagnostics Market, By Application
11.5.5 Latin America Cancer Diagnostics Market, By Cancer Type
11.5.6 Latin America Cancer Diagnostics Market, By End-Use
11.5.7 Brazil
11.5.7.1 Brazil Cancer Diagnostics Market, By Product Type
11.5.7.2 Brazil Cancer Diagnostics Market, By Technology
11.5.7.3 Brazil Cancer Diagnostics Market, By Application
11.5.7.4 Brazil Cancer Diagnostics Market, By Cancer Type
11.5.7.5 Brazil Cancer Diagnostics Market, By End-Use
11.5.8 Others
11.5.8.1 Others Cancer Diagnostics Market, By Product Type
11.5.8.2 Others Cancer Diagnostics Market, By Technology
11.5.8.3 Others Cancer Diagnostics Market, By Application
11.5.8.4 Others Cancer Diagnostics Market, By Cancer Type
11.5.8.5 Others Cancer Diagnostics Market, By End-Use
11.6 Middle East and Africa (MEA)
11.6.1 Middle East and Africa (MEA) Cancer Diagnostics Market, By Country
11.6.2 Middle East and Africa (MEA) Cancer Diagnostics Market, By Product Type
11.6.3 Middle East and Africa (MEA) Cancer Diagnostics Market, By Technology
11.6.4 Middle East and Africa (MEA) Cancer Diagnostics Market, By Application
11.6.5 Middle East and Africa (MEA) Cancer Diagnostics Market, By Cancer Type
11.6.6 Middle East and Africa (MEA) Cancer Diagnostics Market, By End-Use
11.6.7 United Arab Emirates
11.6.7.1 United Arab Emirates Cancer Diagnostics Market, By Product Type
11.6.7.2 United Arab Emirates Cancer Diagnostics Market, By Technology
11.6.7.3 United Arab Emirates Cancer Diagnostics Market, By Application
11.6.7.4 United Arab Emirates Cancer Diagnostics Market, By Cancer Type
11.6.7.5 United Arab Emirates Cancer Diagnostics Market, By End-Use
11.6.8 Others
11.6.8.1 Others Cancer Diagnostics Market, By Product Type
11.6.8.2 Others Cancer Diagnostics Market, By Technology
11.6.8.3 Others Cancer Diagnostics Market, By Application
11.6.8.4 Others Cancer Diagnostics Market, By Cancer Type
11.6.8.5 Others Cancer Diagnostics Market, By End-Use
Chapter 12 Competitive Landscape
12.1 Strategic Move Analysis
12.1.1 Top Player Positioning/Market Share Analysis
12.1.2 Top Winning Strategies, By Year, 2021-2024
12.1.3 Competitive Analysis by Revenue, 2022-2024
12.2 Recent Developments by the Market Participants (2024-25)
Chapter 13 Company Profiles
13.1 GE Healthcare
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Performance
13.1.4 Product Portfolio
13.1.5 Strategic Growth
13.2 Siemens Healthineers
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Performance
13.2.4 Product Portfolio
13.2.5 Strategic Growth
13.3 Philips Healthcare
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Performance
13.3.4 Product Portfolio
13.3.5 Strategic Growth
13.4 Hologic Inc.
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Performance
13.4.4 Product Portfolio
13.4.5 Strategic Growth
13.5 F. Hoffmann-La Roche Ltd.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Performance
13.5.4 Product Portfolio
13.5.5 Strategic Growth
13.6 Thermo Fisher Scientific Inc.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Performance
13.6.4 Product Portfolio
13.6.5 Strategic Growth
13.7 Abbott Laboratories
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Performance
13.7.4 Product Portfolio
13.7.5 Strategic Growth
13.8 Agilent Technologies Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Performance
13.8.4 Product Portfolio
13.8.5 Strategic Growth
13.9 Illumina Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Performance
13.9.4 Product Portfolio
13.9.5 Strategic Growth
13.10 Becton, Dickinson and Company
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Performance
13.10.4 Product Portfolio
13.10.5 Strategic Growth
13.11 Qiagen N.V.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Performance
13.11.4 Product Portfolio
13.11.5 Strategic Growth
13.12 Myriad Genetics Inc.
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Performance
13.12.4 Product Portfolio
13.12.5 Strategic Growth
13.13 Exact Sciences Corporation
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Performance
13.13.4 Product Portfolio
13.13.5 Strategic Growth
13.14 Bio-Rad Laboratories Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Performance
13.14.4 Product Portfolio
13.14.5 Strategic Growth

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us